Ardelyx Balance Sheet
NASDAQ: ARDXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ardelyx financial position
At the end of fiscal 2025, Ardelyx reported total assets of $501.6 million, up 15.1% from a year earlier against total liabilities of $334.7 million. Shareholders' equity stood at $166.9 million, or 33.3% of assets. The company held $68.0 million in cash and equivalents against $202.8 million of debt, a net debt position of $134.8 million.
The current ratio (current assets divided by current liabilities) was 4.31, meaning short-term assets cover obligations due within a year. Debt-to-equity was 1.21.
Summary generated from market data by MetaCap's automated system. Methodology
Ardelyx balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 68.00M | 64.93M | 21.47M | 96.14M | 72.43M | 91.03M | 181.13M | 78.77M | 75.38M | 74.60M |
| Short-Term Investments | 196.69M | 185.17M | 162.83M | 27.77M | 44.26M | 95.45M | 66.38M | 89.32M | 58.59M | 126.22M |
| Receivables | 71.85M | 57.70M | 22.03M | 7.73M | 502.00K | 0 | — | — | — | — |
| Inventory | 123.11M | 91.18M | 49.49M | 28.35M | 0 | — | — | — | — | — |
| Total Current Assets | 382.32M | 356.45M | 246.11M | 153.60M | 133.65M | 194.69M | 252.06M | 176.37M | 149.71M | 203.99M |
| Property, Plant & Equipment | 2.18M | 1.50M | 1.01M | 1.22M | 2.36M | 1.94M | 3.44M | 5.61M | 8.03M | 8.99M |
| Long-Term Investments | — | — | — | — | 0 | 2.11M | — | — | — | — |
| Total Assets | 501.60M | 435.75M | 297.58M | 190.07M | 149.91M | 201.56M | 259.78M | 183.33M | 157.90M | 213.13M |
| Accounts Payable | 19.23M | 16.00M | 11.14M | 10.86M | 4.28M | 5.63M | 2.19M | 1.15M | 3.93M | 5.63M |
| Short-Term Debt | — | — | — | — | 32.26M | — | — | — | — | — |
| Total Current Liabilities | 88.61M | 77.83M | 50.39M | 65.60M | 52.82M | 28.42M | 22.22M | 17.73M | 17.87M | 19.20M |
| Long-Term Debt | 202.83M | 150.85M | 49.82M | 26.71M | 32.26M | 50.79M | 50.01M | 51.98M | — | — |
| Total Liabilities | 334.65M | 262.46M | 130.76M | 91.74M | 67.30M | 75.45M | 73.13M | 67.52M | 18.59M | 19.98M |
| Shareholders' Equity | 166.95M | 173.29M | 166.82M | 98.33M | 82.62M | 126.11M | 186.66M | 115.81M | 139.31M | 193.15M |
| Retained Earnings | -946.94M | -885.34M | -846.20M | -780.14M | -712.93M | -554.76M | -460.45M | -365.51M | -278.21M | -213.88M |
| Total Debt | 202.83M | 150.85M | 49.82M | 26.71M | 64.53M | 50.79M | 50.01M | 51.98M | — | — |
| Net Cash (Debt) | 61.85M | 99.25M | 134.48M | 97.20M | 52.16M | 135.70M | 197.50M | 116.11M | 133.98M | 200.82M |
| Shares Outstanding | 244.35M | 238.02M | 232.45M | 198.58M | 130.18M | 93.60M | 88.82M | 62.52M | 47.53M | 47.31M |
This table shows 10 annual periods of Ardelyx's balance sheet, from FY 2025 back to FY 2016, across 18 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow ARDX's reporting calendar. What is a balance sheet?